Predictive Multiscale Modeling of Microbial Consortia Biofilms

微生物群落生物膜的预测多尺度建模

基本信息

  • 批准号:
    9342881
  • 负责人:
  • 金额:
    $ 32.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-30 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Biofilms are ubiquitous in medical, environmental, and engineered microbial systems. The majority of naturally occurring microbes grow as mixed species biofilms. These complicated biofilm consortia are comprised of a large number of cell phenotypes with complex interactions and self-organize into three-dimensional structures. While foundational to the vast majority of microbial life on the planet, the basic design principles of consortia biofilms are still poorly understood. We believe that a combination of computational and experimental tools is needed to address the challenge of characterizing, predicting and treating these complex systems. The overarching goal of this project is to develop an experimentally driven, predictive multiscale model that generates quantitatively accurate predictions of biofilm formation dynamics, species distributions and responses to perturbations. The biofilm model will be formulated by combining genome-scale metabolic reconstructions of individual species with reaction-diffusion equations for nutrient, metabolic byproduct and antibiotic transport through the biofilm. The biofilm model will be multiscale with respect to both time and length scales, with the metabolic models linking individual genes to cellular dynamics and the consortia model linking individual cells to community dynamics. The research will be developed using a medically relevant, three species chronic wound model system. Treatment of chronic wounds costs the US in excess of $25 billion per year and the costs are anticipated to grow rapidly due to the rise in diabetes and obesity. The specific aims of the proposed research are: (1) construct and evaluate a multiscale metabolic modeling framework for multispecies consortia biofilms in a dynamic, spatially resolved format; (2) develop and implement spatially resolved biofilm analytical methods to quantify physiologies of consortia and monoculture biofilms to inform and validate the computational model; and (3) predict and test spatially resolved metabolic responses to culturing perturbations including antibiotic treatments with iterative loops of hypothesis refinement. Expected outcomes of the proposed research are: (1) a general methodology and associated software tools for multiscale modeling of microbial biofilms to predict consortia dynamics in heterogeneous environments suitable for distribution to the multiscale modeling community; (2) experimental tools for spatially-resolved measurement of mass and energy balances within interacting consortia biofilms; (3) the first perturbation analysis of monoculture and multispecies chronic wound biofilms to nutrient variations and antibiotic treatments; and (4) proposed therapeutic strategies for effectively treating microbial consortia biofilms.
描述(由申请人提供):生物膜在医学、环境和工程微生物系统中普遍存在。大多数天然存在的微生物以混合物种生物膜的形式生长。这些复杂的生物膜聚生体由大量具有复杂相互作用的细胞表型组成,并自组织成三维结构。虽然是地球上绝大多数微生物生命的基础,但对聚生体生物膜的基本设计原理仍然知之甚少。我们认为,需要结合计算和实验工具来解决表征,预测和治疗这些复杂系统的挑战。该项目的总体目标是开发一个实验驱动的,预测多尺度模型,产生定量准确的预测生物膜形成动态,物种分布和扰动的反应。生物膜模型将通过将单个物种的基因组规模的代谢重建与营养物、代谢副产物和抗生素通过生物膜运输的反应扩散方程相结合来制定。生物膜模型将是多尺度的, 时间和长度尺度,与代谢模型连接个别基因的细胞动力学和财团模型连接个别细胞的社区动态。该研究将使用医学相关的三种慢性伤口模型系统进行开发。美国每年治疗慢性伤口的费用超过250亿美元,并且由于糖尿病和肥胖症的增加,预计费用将迅速增长。本研究的具体目标是:(1)构建和评估多物种聚生体生物膜的多尺度动态空间分辨代谢模型框架;(2)开发和实施空间分辨生物膜分析方法,以量化聚生体和单培养生物膜的生理学,为计算模型提供信息和验证;和(3)预测和测试对培养扰动的空间分辨代谢响应,包括用假设细化的迭代循环的抗生素处理。该研究的预期成果是:(1)用于微生物生物膜多尺度建模的一般方法和相关软件工具,以预测适合分布到多尺度建模社区的异质环境中的聚生体动态;(2)用于相互作用的聚生体生物膜内的质量和能量平衡的空间分辨测量的实验工具;(3)第一扰动分析 单一培养物和多物种慢性伤口生物膜对营养变化和抗生素治疗的影响;以及(4)提出了有效治疗微生物聚生体生物膜的治疗策略。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Limitation by a shared mutualist promotes coexistence of multiple competing partners.
  • DOI:
    10.1038/s41467-021-20922-0
  • 发表时间:
    2021-01-27
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Hammarlund SP;Gedeon T;Carlson RP;Harcombe WR
  • 通讯作者:
    Harcombe WR
Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
  • DOI:
    10.1186/s12918-017-0522-1
  • 发表时间:
    2017-12-28
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Henson MA;Phalak P
  • 通讯作者:
    Phalak P
Multiscale analysis of autotroph-heterotroph interactions in a high-temperature microbial community.
  • DOI:
    10.1371/journal.pcbi.1006431
  • 发表时间:
    2018-09
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Hunt KA;Jennings RM;Inskeep WP;Carlson RP
  • 通讯作者:
    Carlson RP
Pseudomonas aeruginosa reverse diauxie is a multidimensional, optimized, resource utilization strategy.
  • DOI:
    10.1038/s41598-020-80522-8
  • 发表时间:
    2021-01-14
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    McGill SL;Yung Y;Hunt KA;Henson MA;Hanley L;Carlson RP
  • 通讯作者:
    Carlson RP
Suboptimal community growth mediated through metabolite crossfeeding promotes species diversity in the gut microbiota.
  • DOI:
    10.1371/journal.pcbi.1006558
  • 发表时间:
    2018-10
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Henson MA;Phalak P
  • 通讯作者:
    Phalak P
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ross P. Carlson其他文献

Pseudomonad reverse carbon catabolite repression, interspecies metabolite exchange, and consortial division of labor
  • DOI:
    10.1007/s00018-019-03377-x
  • 发表时间:
    2019-11-25
  • 期刊:
  • 影响因子:
    6.200
  • 作者:
    Heejoon Park;S. Lee McGill;Adrienne D. Arnold;Ross P. Carlson
  • 通讯作者:
    Ross P. Carlson
Chondrocytes Embedded in Agarose Generate Distinct Metabolic Heat Profiles Based on Media Carbon Sources
  • DOI:
    10.1007/s10439-025-03755-6
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    5.400
  • 作者:
    Erik Myers;Priyanka Brahmachary;Sarah Mensah;Campbell Putnam;Ross P. Carlson;Mark Greenwood;Ronald K. June
  • 通讯作者:
    Ronald K. June
Pseudomonas aeruginosa reverse diauxie is an optimized, resource utilization strategy
铜绿假单胞菌反向双效是一种优化的资源利用策略
  • DOI:
    10.1101/2020.07.28.224436
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Lee McGill;Yeni P. Yung;K. A. Hunt;Michael A. Henson;Luke Hanley;Ross P. Carlson
  • 通讯作者:
    Ross P. Carlson
Genome sequence, phylogenetic analysis, and structure-based annotation reveal metabolic potential of emChlorella/em sp. SLA-04
基因组序列、系统发育分析和基于结构的注释揭示了 emChlorella sp. SLA-04 的代谢潜能
  • DOI:
    10.1016/j.algal.2022.102943
  • 发表时间:
    2023-01-01
  • 期刊:
  • 影响因子:
    4.500
  • 作者:
    Calvin L.C. Goemann;Royce Wilkinson;William Henriques;Huyen Bui;Hannah M. Goemann;Ross P. Carlson;Sridhar Viamajala;Robin Gerlach;Blake Wiedenheft
  • 通讯作者:
    Blake Wiedenheft

Ross P. Carlson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ross P. Carlson', 18)}}的其他基金

Predictive Multiscale Modeling of Microbial Consortia Biofilms
微生物群落生物膜的预测多尺度建模
  • 批准号:
    8797712
  • 财政年份:
    2014
  • 资助金额:
    $ 32.36万
  • 项目类别:
Predictive Multiscale Modeling of Microbial Consortia Biofilms
微生物群落生物膜的预测多尺度建模
  • 批准号:
    9123584
  • 财政年份:
    2014
  • 资助金额:
    $ 32.36万
  • 项目类别:
SYSTEMS BIOLOGY OF HOST-PATHOGEN INTERACTIONS
宿主-病原体相互作用的系统生物学
  • 批准号:
    8359568
  • 财政年份:
    2011
  • 资助金额:
    $ 32.36万
  • 项目类别:
SYSTEMS BIOLOGY OF HOST-PATHOGEN INTERACTIONS
宿主-病原体相互作用的系统生物学
  • 批准号:
    8167558
  • 财政年份:
    2010
  • 资助金额:
    $ 32.36万
  • 项目类别:
SYSTEMS BIOLOGY OF HOST-PATHOGEN INTERACTIONS
宿主-病原体相互作用的系统生物学
  • 批准号:
    7960479
  • 财政年份:
    2009
  • 资助金额:
    $ 32.36万
  • 项目类别:

相似海外基金

SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
  • 批准号:
    2213034
  • 财政年份:
    2023
  • 资助金额:
    $ 32.36万
  • 项目类别:
    Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
  • 批准号:
    10645528
  • 财政年份:
    2023
  • 资助金额:
    $ 32.36万
  • 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
  • 批准号:
    10736285
  • 财政年份:
    2023
  • 资助金额:
    $ 32.36万
  • 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
  • 批准号:
    10603486
  • 财政年份:
    2023
  • 资助金额:
    $ 32.36万
  • 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
  • 批准号:
    449379
  • 财政年份:
    2020
  • 资助金额:
    $ 32.36万
  • 项目类别:
    Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
  • 批准号:
    422034
  • 财政年份:
    2020
  • 资助金额:
    $ 32.36万
  • 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
  • 批准号:
    nhmrc : 1197866
  • 财政年份:
    2020
  • 资助金额:
    $ 32.36万
  • 项目类别:
    Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
  • 批准号:
    2241853
  • 财政年份:
    2019
  • 资助金额:
    $ 32.36万
  • 项目类别:
    Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
  • 批准号:
    18K07106
  • 财政年份:
    2018
  • 资助金额:
    $ 32.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
  • 批准号:
    9788269
  • 财政年份:
    2018
  • 资助金额:
    $ 32.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了